You can buy or sell NKTR and other stocks, options, ETFs, and crypto commission-free!
Nektar Therapeutics Common Stock, also called Nektar Therapeutics, is a biopharmaceutical company, which engages in applying technology platforms to develop novel drug candidates. The company focuses on the therapies for cancer, autoimmune disease, and chronic pain. Read More It operates through the United States and Europe geographical segments. The company was founded in 1990 and is headquartered in San Francisco, CA.
San Francisco, California
52 Week High
52 Week Low
Expected Nov 7, After Hours
Nektar Therapeutics, Bristol-Myers Squibb Company - Nektar Therapeutics Tumbles To 2-Year Low On Q2 Revenue Miss, Manufacturing Issues With Cancer Drug